Literature DB >> 10595503

Neurodegenerative tauopathies: human disease and transgenic mouse models.

V M Lee1, J Q Trojanowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10595503     DOI： 10.1016/s0896-6273(00)81106-x

Source DB:  PubMed          Journal:  Neuron        ISSN： 0896-6273            Impact factor:   17.173


× No keyword cloud information.
  22 in total

Review 1.  Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics.

Authors:  P C Wong; H Cai; D R Borchelt; D L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

2.  Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau.

Authors:  Kentaro Tanemura; Miyuki Murayama; Takumi Akagi; Tsutomu Hashikawa; Takashi Tominaga; Michinori Ichikawa; Haruyasu Yamaguchi; Akihiko Takashima
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.

Authors:  T Ishihara; B Zhang; M Higuchi; Y Yoshiyama; J Q Trojanowski; V M Lee
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

4.  Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice.

Authors:  S Capsoni; G Ugolini; A Comparini; F Ruberti; N Berardi; A Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

5.  Tau is essential to beta -amyloid-induced neurotoxicity.

Authors:  Mark Rapoport; Hana N Dawson; Lester I Binder; Michael P Vitek; Adriana Ferreira
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

6.  Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation.

Authors:  Takashi Saito; Naomi Mihira; Yukio Matsuba; Hiroki Sasaguri; Shoko Hashimoto; Sneha Narasimhan; Bin Zhang; Shigeo Murayama; Makoto Higuchi; Virginia M Y Lee; John Q Trojanowski; Takaomi C Saido
Journal:  J Biol Chem       Date:  2019-07-04       Impact factor: 5.157

7.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

8.  Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.

Authors:  Suhail Rasool; Hilda Martinez-Coria; Jessica W Wu; Frank LaFerla; Charles G Glabe
Journal:  J Neurochem       Date:  2013-06-16       Impact factor: 5.372

9.  Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice.

Authors:  Suhail Rasool; Hilda Martinez-Coria; Saskia Milton; Charles G Glabe
Journal:  Mol Neurobiol       Date:  2013-06-15       Impact factor: 5.590

10.  Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.

Authors:  Yoshitaka Tatebayashi; Tomohiro Miyasaka; De-Hua Chui; Takumi Akagi; Ken-ichi Mishima; Katsunori Iwasaki; Michihiro Fujiwara; Kentaro Tanemura; Miyuki Murayama; Koichi Ishiguro; Emmanuel Planel; Shinji Sato; Tsutomu Hashikawa; Akihiko Takashima
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.